ÀÏÀß·¯Ã¤¿ë°ü
ä¿ëÁ¤º¸
ÀÎÀç°Ë»ö
±³À°Á¤º¸
ÇìµåÇåÆÃ
½º¸¶Æ®Å¸¿î
ȸ¿ø¼­ºñ½º
À̷¼­ µî·Ï
ä¿ë°ø°í µî·Ï

2013 »ó¹Ý±â ½ÅÀÔ°øÃ¤ Global ÀÎÀçä¿ë

¾÷Á¾ È­ÇÐ, °í¹«, ÇÃ¶ó½ºÆ½ ÀÚº»±Ý
±â¾÷ÇüÅ ´ë±â¾÷ ¸ÅÃâÇöȲ
´ëÇ¥ÀÚ »ç¿ø¼ö
ȸ»çÁÖ¼Ò (463-400) °æ±â ¼º³²½Ã ºÐ´ç±¸ »ïÆòµ¿ 686
  • ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù.
  • ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.




Á÷Á¾ È­ÇС¤È­°ø
±Ù¹«ÇüÅ Á¤±ÔÁ÷ ä¿ëÁ÷±Þ -
¸ðÁýÀοø 0 ¸í ³ªÀÌ Á¦ÇѾøÀ½
°æ·Â ½ÅÀÔ ±Þ¿©Á¶°Ç ¸éÁ¢½ÃÇùÀÇ
Çз ´ëÁ¹ ÀÌ»ó Á¢¼ö±â°£ Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù
 [ȨÆäÀÌÁöÁ¢¼ö]

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

* ´ã´ç¾÷¹«
»ó¼¼Á¶°Ç

¡Ü  ä¿ëÀ¯Çü

   - ½ÅÀÔ/°æ·Â


¡Ü  Á÷¹«¼³¸í

   1) Polymerization

      - Specialty Polymer

         ¡Ø Development of new polymers and bio-based polymers s ynthesis

         ¡Ø Development of new applications for various industries  

   2) Polyester Resins

      - Specialty Polymer

         ¡Ø Development of e co- friendly polyester resins for adhesives and coating

             (Polymerization/Polymer Processing)

   3) Injection or Extrusion

      - Specialty Polymer

         ¡Ø D evelopment of polymer processing (PLA and bio-based polymers)

   4) Compounding

      - Specialty Polymer

         ¡Ø Development of engineering polymers (EP and Super EP) compounding    

   5) ESS(Energy Storage System)

      - New Business

         ¡Ø Development of ESS materials and system• Evaluation of ESS performance

         ¡Ø New b usiness development o f ESS project  

   6) Certification

      - Analytical Chemistry

         ¡Ø Registering chemicals and polymers to overseas

         ¡Ø Certification of Food contact & Medical device, etc.

   7) Global Marketing

      - Life Science

         ¡Ø Exporting the pharmaceutical technology

         ¡Ø Approval drug products for the global market

   8) Synthetic/Natural Drugs

      - New Drugs

         ¡Ø Evaluation of pharmacological and therapeutic effects using in vitro and in vivo models

         ¡Ø Drug design and synthesis of small organic molecules

         ¡Ø Computer modeling for drug discovery

         ¡Ø Analytical expertise for CTD documentation and method development

         ¡Ø Drug evaluation by toxicological background

   9) Vaccines

      - Bio Drugs

         ¡Ø Process development of biological production

         ¡Ø Research experience of vaccine products

         ¡Ø Development of biological assay  


¡Ü  Á¢¼ö±â°£ ¹× Á¢¼ö¹æ¹ý

   1) Á¢¼ö±â°£

      - 2013³â 03¿ù 28ÀÏ (¸ñ) ~ 2013³â 04¿ù 22ÀÏ (¿ù) ±îÁö

   2) Á¢¼ö¹æ¹ý

      - ´ç»ç ȨÆäÀÌÁö Á¢¼ö ÀÌ¿ë


¡Ü  ¹®ÀÇó

   - kimsm@sk.com or msna@sk.com



* ÀÔ»çÁö¿ø ½Ã Áß¿ä»çÇ×À» ²À üũÇϼ¼¿ä!

* ±Ù¹«È¯°æ
±Ù¹«Áö¿ª : °æ±â
±Þ¿©Á¶°Ç : ¸éÁ¢½ÃÇùÀÇ
* Á¢¼ö°³¿ä

¿À´Ã¸¶°¨

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

¡á Á¢¼ö±â°£   ¡á ¿À´Ã   ¡á ¸¶°¨

2013. 04

  • ÀÏ
  • ¿ù
  • È­
  • ¼ö
  • ¸ñ
  • ±Ý
  • Åä
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
* ´ã´çÀÚ Á¤º¸
¸ðÁý±â°£ÀÌ Áö³­ ä¿ëÁ¤º¸ÀÇ °æ¿ì ´ã´çÁ¤º¸´Â °ø°³µÇÁö ¾Ê½À´Ï´Ù.
ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù. ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.

µî·Ï : 2013³â 4¿ù 1ÀÏ (¿ù) 10:25    ÃÖÁ¾¼öÁ¤ : 2013³â 4¿ù 10ÀÏ (¼ö) 16:00

º» Á¤º¸´Â SKÄɹÌÄ®(ÁÖ) ¿¡¼­ Á¦°øÇÑ ÀÚ·áÀ̸ç, ½ºÄ«¿ìÆ®Àº(´Â) ±× ³»¿ë»óÀÇ ¿À·ù ¹× Áö¿¬, ±× ³»¿ëÀ» ½Å·ÚÇÏ¿© ÃëÇØÁø Á¶Ä¡¿¡ ´ëÇÏ¿© Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. º» Á¤º¸´Â ½ºÄ«¿ìÆ®ÀÇ µ¿ÀÇ ¾øÀÌ Àç¹èÆ÷ÇÒ ¼ö ¾ø½À´Ï´Ù.

¢À ½ºÄ«¿ìÆ® ¿¡¼­´Â °ÅÁþ ±¸ÀÎ ±¤°í¿¡ ´ëÇÑ ÇÇÇØ¸¦ ÃÖ¼ÒÈ­ Çϱâ À§ÇÏ¿© ÇãÀ§ ä¿ë°ø°í¿¡ ½Å°íÁ¦µµ¸¦ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù.
°ÅÁþ±¸Àα¤°í¿¡ ´ëÇÑ ±¸Á÷ÀÚÁÖÀÇ»çÇ× ½Å°íÆ÷»ó±ÝÁ¦ ¾È³» ÇãÀ§ ä¿ë°ø°í ½Å°íÇϱâ

±Ù¹«Áö À§Ä¡ º¸±â

±Ù¹«Áö ÁÖ¼Ò

(463-400) °æ±â ¼º³²½Ã ºÐ´ç±¸ »ïÆòµ¿ 686

Å©°Ôº¸±â

[ƯÁý±âȹ] ¹ý·ü»ç¹«Á÷

Á÷¾÷µ¸º¸±â

¹ý·ü»ç¹«Á÷À̶õ?º¯..

¸éÁ¢ helper

¸éÁ¢Áú¹®

Àμº ¡Ú¡Ú¡Ú¡Ú
Àû¼º ¡Ú¡Ú¡Ú¡Ú

Special Interview

½ºÆä¼ÈÀÎÅͺä
¹ý·ü »ç¹«Á÷À̶ó´Â ÀÏÀÌ ¾î¶² ÀÏÀÎÁö Àß ¸ð..

À¯»çÁ÷Á¾ÀÇ Ã¤¿ë Á¤º¸